세계의 바이오의약품 제3자 물류 시장 보고서(2025년)

Biopharmaceutical third-party logistics involves external partners or services that facilitate the provision of logistics services to pharmaceutical companies. These companies outsource their transportation needs to third-party providers as a cost-saving measure, and the lack of in-house capabilities significantly contributes to the growing trend of transportation outsourcing.

The primary categories of supply chains in biopharmaceutical third-party logistics are cold chain and non-cold chain. The cold chain specifically pertains to a supply chain that ensures temperature control throughout the transportation of products sensitive to temperature variations. Various services, including transportation, warehousing and storage, among others, are utilized by pharmaceutical and biopharmaceutical companies, medical device companies, hospitals and clinics, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biopharmaceutical third-party logistics market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical third-party logistics market statistics, including biopharmaceutical third-party logistics industry global market size, regional shares, competitors with a biopharmaceutical third-party logistics market share, detailed biopharmaceutical third-party logistics market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical third-party logistics industry. This biopharmaceutical third-party logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $141.59 billion in 2024 to $150.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics.

The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $203.18 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, COVID-19 impact. Major trends in the forecast period include on-demand logistics solutions, sustainability in logistics, last-mile delivery solutions, pharma serialization and traceability, autonomous logistics.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug distribution by inflating prices of temperature-controlled shipping solutions and track-and-trace systems developed in Germany and the Netherlands, resulting in compromised cold chain integrity and higher logistics costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing trend of outsourcing logistics is projected to drive the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics entails engaging a third party to manage all or part of a company's logistical activities. In the biopharmaceutical sector, this practice is utilized for outsourcing cryogenic supply chain management to logistics partners. For instance, in February 2024, the Bureau of Transportation Statistics, a U.S. agency under the Department of Transportation (DOT), reported a 1.8% increase in for-hire freight shipments in December 2023 compared to December 2022, while the Freight Transportation Services Index rose from 136.6 in December 2022 to 139.1 in December 2023. Thus, the increasing trend of outsourcing logistics is expected to propel the growth of the biopharmaceutical third-party logistics market.

The introduction of innovative biopharmaceutical products is anticipated to drive the growth of the biopharmaceutical third-party logistics market. Innovative biopharmaceutical products are advanced and novel therapeutic substances derived from biological sources, such as monoclonal antibodies or gene therapies. The biopharmaceutical third-party logistics market plays a vital role in the efficient launch of these products by providing streamlined supply chain solutions, ensuring timely and secure distribution, and supporting the complex logistics involved in bringing these innovative therapies to market. For instance, in January 2024, the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a U.S. branch of the Food and Drug Administration (FDA), indicated that the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the launch of innovative biopharmaceutical products is expected to propel the growth of the biopharmaceutical third-party logistics market.

Technological advancements stand out as a prominent trend gaining momentum in the biopharmaceutical third-party logistics market. Major companies within this market are strategically launching innovative products to fortify their market position and gain a competitive edge. For example, in November 2022, Celcius Logistics Solutions Pvt Ltd., an India-based logistics services provider, introduced Hyper-Local temperature-controlled delivery services designed for food and pharmaceutical orders. The company's last-mile solution, catering to smaller quantities, is available in nine cities across the country. The hyperlocal approach ensures optimal material quality during transportation by continuously monitoring temperatures in real-time at each stage of the delivery process.

Major companies in the biopharmaceutical third-party logistics market are concentrating on innovative solutions, such as expanding their operations in life sciences and healthcare logistics, to enhance their logistics capabilities for pharmaceutical and healthcare products, ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics refers to the strategic growth of logistics companies to improve their capabilities in transporting and managing medical products, which is essential for ensuring timely delivery and maintaining the integrity of temperature-sensitive items crucial for patient care. For example, in August 2022, DHL Supply Chain, a Germany-based contract logistics specialist of Deutsche Post DHL Group, announced the expansion of its Life Sciences and Healthcare Campus in Florstadt, Germany. This expansion includes the construction of a new logistics center that will add 32,000 square meters of space dedicated to the storage and distribution of pharmaceutical and medical products. The facility will feature various temperature-controlled zones and have the capacity for 10,000 pallet locations, enabling it to handle a wide range of pharmaceutical products. This initiative aims to enhance DHL's capabilities in pharmaceutical logistics and support the increasing demands of the healthcare sector, ensuring efficient and compliant handling of sensitive medical supplies.

In March 2022, STG Logistics Inc., a US-based provider of optimized logistics and transportation services, successfully acquired the intermodal division of XPO Logistics Inc. for $710 million. This strategic move enhances STG Logistics' position in the containerized logistics industry, paving the way for further achievements. XPO Logistics Inc. is a US-based provider of asset-based less-than-truckload (LTL) freight transportation and third-party logistics, including biopharma logistics.

Major companies operating in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services

North America was the largest region in the biopharmaceutical third party logistics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biopharmaceutical third-party logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biopharmaceutical third-party logistics market consists of revenues earned by entities by providing biopharmaceutical third-party logistics such as domestic transportation management, international transportation management, and value-added warehousing and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Third-Party Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical third-party logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical third-party logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical third-party logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Supply Chain: Cold Chain; Non-Cold Chain
• 2) By Service: Transportation; Warehousing And Storage; Other Services
• 3) By End-User: Pharmaceutical And Biopharmaceutical Companies; Medical Device Companies; Hospitals And Clinics; Other End-Users
• Subsegments:
• 1) By Cold Chain: Refrigerated Transport; Temperature-Controlled Storage; Specialized Packaging
• 2) By Non-Cold Chain: Ambient Transport; Standard Storage Solutions; General Packaging Methods
• Companies Mentioned: McKesson Corporation; AmerisourceBergen Corporation; United Parcel Service of America Inc.; FedEx Corporation; DHL International GmbH; Kuehne + Nagel International AG; SF Express Co Ltd.; DB Schenker; CH Robinson Worldwide Inc.; Nippon Express Group; Expeditors International of Washington Inc.; Sinotrans Limited; XPO Logistics Inc.; Kerry Logistics Network Limited; Bollore Logistics; Catalent Inc.; Almac Group; VersaCold Logistics Services; Cryoport Inc.; Agility Logistics Corp; Fisher Clinical Services; CEVA Logistics Inc.; LifeScience Logistics; Cold Chain Technologies LLC; Langham Logistics; Airpharm Logistics; Express Courier International; Bio Pharma Logistics; PCI Pharma Services
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biopharmaceutical Third-Party Logistics Market Characteristics

3. Biopharmaceutical Third-Party Logistics Market Trends And Strategies

4. Biopharmaceutical Third-Party Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biopharmaceutical Third-Party Logistics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biopharmaceutical Third-Party Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biopharmaceutical Third-Party Logistics Market Growth Rate Analysis
• 5.4. Global Biopharmaceutical Third-Party Logistics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biopharmaceutical Third-Party Logistics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biopharmaceutical Third-Party Logistics Total Addressable Market (TAM)

6. Biopharmaceutical Third-Party Logistics Market Segmentation

• 6.1. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cold Chain
• Non-Cold Chain
• 6.2. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transportation
• Warehousing And Storage
• Other Services
• 6.3. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biopharmaceutical Companies
• Medical Device Companies
• Hospitals And Clinics
• Other End-Users
• 6.4. Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Refrigerated Transport
• Temperature-Controlled Storage
• Specialized Packaging
• 6.5. Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Non-Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambient Transport
• Standard Storage Solutions
• General Packaging Methods

7. Biopharmaceutical Third-Party Logistics Market Regional And Country Analysis

• 7.1. Global Biopharmaceutical Third-Party Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biopharmaceutical Third-Party Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical Third-Party Logistics Market

• 8.1. Asia-Pacific Biopharmaceutical Third-Party Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical Third-Party Logistics Market

• 9.1. China Biopharmaceutical Third-Party Logistics Market Overview
• 9.2. China Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical Third-Party Logistics Market

• 10.1. India Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical Third-Party Logistics Market

• 11.1. Japan Biopharmaceutical Third-Party Logistics Market Overview
• 11.2. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical Third-Party Logistics Market

• 12.1. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical Third-Party Logistics Market

• 13.1. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical Third-Party Logistics Market

• 14.1. South Korea Biopharmaceutical Third-Party Logistics Market Overview
• 14.2. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical Third-Party Logistics Market

• 15.1. Western Europe Biopharmaceutical Third-Party Logistics Market Overview
• 15.2. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical Third-Party Logistics Market

• 16.1. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical Third-Party Logistics Market

• 17.1. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical Third-Party Logistics Market

• 18.1. France Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical Third-Party Logistics Market

• 19.1. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical Third-Party Logistics Market

• 20.1. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical Third-Party Logistics Market

• 21.1. Eastern Europe Biopharmaceutical Third-Party Logistics Market Overview
• 21.2. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical Third-Party Logistics Market

• 22.1. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical Third-Party Logistics Market

• 23.1. North America Biopharmaceutical Third-Party Logistics Market Overview
• 23.2. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical Third-Party Logistics Market

• 24.1. USA Biopharmaceutical Third-Party Logistics Market Overview
• 24.2. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical Third-Party Logistics Market

• 25.1. Canada Biopharmaceutical Third-Party Logistics Market Overview
• 25.2. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical Third-Party Logistics Market

• 26.1. South America Biopharmaceutical Third-Party Logistics Market Overview
• 26.2. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical Third-Party Logistics Market

• 27.1. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical Third-Party Logistics Market

• 28.1. Middle East Biopharmaceutical Third-Party Logistics Market Overview
• 28.2. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical Third-Party Logistics Market

• 29.1. Africa Biopharmaceutical Third-Party Logistics Market Overview
• 29.2. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical Third-Party Logistics Market Competitive Landscape And Company Profiles

• 30.1. Biopharmaceutical Third-Party Logistics Market Competitive Landscape
• 30.2. Biopharmaceutical Third-Party Logistics Market Company Profiles
  • 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. United Parcel Service of America Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. FedEx Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. DHL International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical Third-Party Logistics Market Other Major And Innovative Companies

• 31.1. Kuehne + Nagel International AG
• 31.2. SF Express Co Ltd.
• 31.3. DB Schenker
• 31.4. CH Robinson Worldwide Inc.
• 31.5. Nippon Express Group
• 31.6. Expeditors International of Washington Inc.
• 31.7. Sinotrans Limited
• 31.8. XPO Logistics Inc.
• 31.9. Kerry Logistics Network Limited
• 31.10. Bollore Logistics
• 31.11. Catalent Inc.
• 31.12. Almac Group
• 31.13. VersaCold Logistics Services
• 31.14. Cryoport Inc.
• 31.15. Agility Logistics Corp

32. Global Biopharmaceutical Third-Party Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market

34. Recent Developments In The Biopharmaceutical Third-Party Logistics Market

35. Biopharmaceutical Third-Party Logistics Market High Potential Countries, Segments and Strategies

• 35.1 Biopharmaceutical Third-Party Logistics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biopharmaceutical Third-Party Logistics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biopharmaceutical Third-Party Logistics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer